GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.25
Bid: 15.00
Ask: 15.50
Change: -0.50 (-3.23%)
Spread: 0.50 (3.333%)
Open: 15.00
High: 15.50
Low: 14.65
Prev. Close: 15.50
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Australia's AGL says approached by Alinta to buy coal-fired Liddell plant

Wed, 04th Apr 2018 03:02

* No formal offer received - AGL

* Liddell slated to be closed in 2022

* Australia government sought Alinta's interest(Adds fresh Alinta MD quote, background)

SYDNEY, April 4 (Reuters) - Australia's biggest energyproducer AGL Energy Ltd said on Wednesday HongKong-owned rival Alinta Energy has expressed interest in buyingits coal-fired Liddell Power Station, which is slated to beclosed.

AGL wants to shutter the plant in 2022 as part of a phasedexit from coal by 2050 so it can become a purely renewableenergy supplier. But the firm has come under pressure fromAustralia's government to sell the power station instead.

AGL said it received "an approach from Alinta last nightexpressing an interest in entering negotiations" to buy theplant, but that no formal bid had been made.

A formal offer "would be given consideration in order tomeet our obligations to customers and shareholders," AGL said inan emailed statement.

Australia's electricity supply business has become a hotpolitical issue in the past year, after a string of blackoutsand price spikes hit households and major industrial usersincluding miners BHP and Rio Tinto.

That has prompted the country's conservative government toscrap some subsidies for renewable projects. This week abreakaway group of lawmakers called for the government toprovide more financial support for new coal-fired plants.

Alinta's Managing Director Jeff Dimery said in a radiointerview on Wednesday that the government had asked hiscompany, which is owned by Hong Kong's Chow Tai Fook EnterprisesLtd, to consider buying Liddell.

"We stated that we had no objection to owning criticalassets required for stability and reliability in the marketplaceas we transition to a low-carbon economy," Dimery toldAustralian Broadcasting Corp radio.

"We conducted some preliminary analysis that led us to anopinion that, at a commercial rate, there's an opportunityhere," he added.

AGL previously rejected the idea of selling the plantbecause it needs Liddell, located north of Sydney, to maintainsupplies to its own customers ahead of the original 2022 closureplan.

"AGL is relying on Liddell to generate power for ourcustomers until 2022 and we will require its infrastructure forour replacement plans into the future," it said on Wednesday.(Reporting by Tom Westbrook in SYDNEY Additional reporting bySumeet Gaikwad in BENGALURUEditing by Byron Kaye and Aaron Sheldrick)

More News
20 Oct 2020 14:18

IN BRIEF: Angle Says FDA Accepts Parsotix Submission For Breast Cancer

IN BRIEF: Angle Says FDA Accepts Parsotix Submission For Breast Cancer

Read more
20 Oct 2020 08:58

FDA accepts Angle's review submission for Parsortix PC1

(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that the US Food and Drug Administration (FDA) has completed its administrative review, and accepted the company's submission for substantive review.

Read more
28 Sep 2020 19:33

IN BRIEF: Angle Submits US FDA De Novo Application For Parsortix

IN BRIEF: Angle Submits US FDA De Novo Application For Parsortix

Read more
20 Aug 2020 16:00

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
14 Aug 2020 12:41

Angle's Parsortix Able To Predict Patients' Response To Treatment

Angle's Parsortix Able To Predict Patients' Response To Treatment

Read more
20 Jul 2020 20:03

IN BRIEF: Angle Notes Study Showing "Key Capabilities" Of Parsortix

IN BRIEF: Angle Notes Study Showing "Key Capabilities" Of Parsortix

Read more
20 Jul 2020 10:16

Angle's 'Parsortix' advantageous in breast cancer in new research

(Sharecast News) - Angle announced on Monday that the University of Southern California (USC) has published peer-reviewed results of new work undertaken in metastatic breast cancer (MBC), highlighting advantages of a 'Parsortix' liquid biopsy, compared to standard-of-care tissue biopsy.

Read more
25 Jun 2020 12:22

Angle Progresses On Parsortix And De Novo Clearance From US Regulator

Angle Progresses On Parsortix And De Novo Clearance From US Regulator

Read more
18 Jun 2020 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
10 Jun 2020 16:41

IN BRIEF: Haydale Graphene Appoints Former AIM Market COO To Board

IN BRIEF: Haydale Graphene Appoints Former AIM Market COO To Board

Read more
12 May 2020 18:54

Angle's Parsortix Could Be Used To Pick MET Inhibitor Trial Subjects

Angle's Parsortix Could Be Used To Pick MET Inhibitor Trial Subjects

Read more
12 May 2020 08:58

Angle upbeat on recent research using 'Parsortix'

(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that the liquid biopsy analysis unit at the Health Research Institute of Santiago in Spain has published results of new work undertaken in head and neck cancer and non small cell lung cancer, on the potential utility of a liquid biopsy-based strategy to assess MET alterations on circulating tumour cells (CTCs).

Read more
28 Apr 2020 12:28

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

Read more
28 Apr 2020 10:03

Angle works with skeleton R&D crew during lockdown

(Sharecast News) - Biopharmaceuticals group Angle said on Tuesday that progress had been impeded by the Covid-19 outbreak as the firm worked with a research and development skeleton crew in Guildford.

Read more
31 Mar 2020 12:21

UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial

UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.